Ads
related to: genentech pharmaceuticals careers
Search results
Results from the WOW.Com Content Network
Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California, wholly owned by the Swiss multinational pharmaceutical company, the Roche Group. It became an independent subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. [6]
Karin Briner is a medicinal chemist and pharmaceutical executive currently employed as Senior Vice President, Head of Drug Discovery at Genentech. ... Scientific career:
In 2013, Anderson moved to Switzerland to be head of global product strategy and chief marketing officer of the pharmaceuticals division at the Roche Holding AG. [9] In July 2016, Anderson returned to the U.S. to lead North American Operations at Roche's subsidiary, Genentech. [6] From 2017 to 2018, he was the CEO of Genentech. [6]
Despite multiple employment offers on the East Coast of the United States, [1] Young chose to remain in the San Francisco Bay Area for her professional career. From 1995 to 2006, Young worked at Celera Genomics, studying inhibitor compounds of human plasma proteins [7] such as kallikrein and Factors VIIa and IXa.
Jim Wells began his independent research career as a co-founding member of the Protein Engineering Department at Genentech.At Genentech, Wells and his group pioneered "gain-of-function engineering" of enzymes (such as subtilisin [2]), growth factors (human growth hormone [3]), and antibodies by site-directed mutagenesis [4] and protein phage display.
1971: The foreign subsidiary, Boehringer Ingelheim Pharmaceuticals, Inc is founded in Ridgefield, Connecticut (USA). This site is soon expanded, and becomes the company's North American research centre. 1985: The Research Institute of Molecular Pathology (IMP) is established in Vienna through a collaboration with Genentech; it opens in 1988.
Ads
related to: genentech pharmaceuticals careers